福瑞股份股价创新高，最新筹码趋向集中

Group 1 - The stock price of Furuya Co., Ltd. reached a historical high, increasing by 2.34% to 73.92 yuan, with a trading volume of 6.4627 million shares and a transaction amount of 470 million yuan, resulting in a turnover rate of 2.77% [2] - The latest total market capitalization of the company in A-shares is 19.587 billion yuan, while the circulating market capitalization is 17.271 billion yuan [2] - The pharmaceutical and biotechnology industry, to which Furuya belongs, has an overall decline of 0.51%, with 90 stocks rising, including Renhe Pharmaceutical, Fangsheng Pharmaceutical, and Huabang Health, which increased by 10.00%, 7.56%, and 7.25% respectively [2] Group 2 - As of August 19, the latest margin trading balance for Furuya is 815 million yuan, with a financing balance of 811 million yuan, reflecting an increase of 143 million yuan over the past 10 days, a growth of 21.36% [2] - The number of shareholders as of August 10 is 17,259, a decrease of 161 from the previous period, representing a decline of 0.92% [2] - The company's Q1 report shows a revenue of 330 million yuan, a year-on-year increase of 2.35%, while net profit is 28.6367 million yuan, a year-on-year decrease of 32.97%, with basic earnings per share at 0.1075 yuan and a weighted average return on equity of 1.63% [2] Group 3 - On July 15, the company released a half-year performance forecast, expecting a net profit between 50 million and 60 million yuan, with a year-on-year change range of -34.00% to -20.00% [3]